We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.47%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$405B
AUM Growth
+$3.26B
Cap. Flow
-$4.73B
Cap. Flow %
-1.17%
Top 10 Hldgs %
17.59%
Holding
10,501
New
1,227
Increased
3,693
Reduced
4,131
Closed
1,043

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.12B
2
AAPL icon
Apple
AAPL
+$1.08B
3
MSFT icon
Microsoft
MSFT
+$1.05B
4
NKE icon
Nike
NKE
+$1.03B
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$821M

Sector Composition

Rank Sector Weight
1 Technology 17.8%
2 Financials 8.25%
3 Healthcare 6.4%
4 Consumer Discretionary 5.85%
5 Communication Services 4.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SDP icon
8901
ProShares UltraShort Utilities
SDP
$4.11M
$371 ﹤0.01%
9
-48
-84% -$2.04K
VWID
8902
DELISTED
Virtus WMC International Dividend ETF
VWID
$370 ﹤0.01%
14
-45
-76% -$1.22K
TDW.WS
8903
DELISTED
Tidewater Inc.
TDW.WS
$368 ﹤0.01%
+35
New +$460
QNCX icon
8904
Quince Therapeutics
QNCX
$22.9M
$360 ﹤0.01%
2
-1
-33% -$181
PLX icon
8905
Protalix BioTherapeutics
PLX
$191M
$359 ﹤0.01%
307
-67,649
-100% -$79.9K
FPXE icon
8906
First Trust IPOX Europe Equity Opportunities ETF
FPXE
$4.94M
$357 ﹤0.01%
14
-172
-92% -$4.34K
ION icon
8907
ProShares S&P Global Core Battery Metals ETF
ION
$11.8M
$356 ﹤0.01%
13
-40
-75% -$1.22K
KLXE icon
8908
KLX Energy Services
KLXE
$45M
$356 ﹤0.01%
72
-12,623
-99% -$75.9K
ALSAR
8909
DELISTED
Alpha Star Acquisition Corp Rights
ALSAR
$354 ﹤0.01%
3,724
+3,700
+15,417% +$427
PSFE.WS
8910
DELISTED
Paysafe Ltd Warrants
PSFE.WS
$353 ﹤0.01%
+14,728
New +$396
SURI icon
8911
Simplify Propel Opportunities ETF
SURI
$77.3M
$353 ﹤0.01%
16
FSLD
8912
DELISTED
Fidelity Sustainable Low Duration Bond ETF
FSLD
$350 ﹤0.01%
7
-74
-91% -$3.71K
LOTWW
8913
DELISTED
Lotus Technology Inc Warrants
LOTWW
$350 ﹤0.01%
934
+933
+93,300% +$456
DPRO
8914
Draganfly
DPRO
$153M
$348 ﹤0.01%
59
-4,345
-99% -$27K
VRME icon
8915
VerifyMe
VRME
$9.38M
$347 ﹤0.01%
+246
New +$397
MSTI icon
8916
Madison Short-Term Strategic Income ETF
MSTI
$48.8M
$345 ﹤0.01%
+17
New +$345
PLAO
8917
DELISTED
Patria Latin American Opportunity Acquisition Corp. Class A Ordinary Shares
PLAO
$343 ﹤0.01%
+30
New +$341
TRIS.WS
8918
DELISTED
Tristar Acquisition I Corp. Redeemable Warrants, each exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
TRIS.WS
$343 ﹤0.01%
2,857
+63
+2% +$8
CARM
8919
DELISTED
Carisma Therapeutics
CARM
$340 ﹤0.01%
224
-26,979
-99% -$40.2K
WGMI icon
8920
CoinShares ETF Trust CoinShares Bitcoin Mining ETF
WGMI
$253M
$339 ﹤0.01%
16
LEV
8921
DELISTED
The Lion Electric Company
LEV
$339 ﹤0.01%
373
-28,481
-99% -$30.2K
KNOW icon
8922
Fundamentals First ETF
KNOW
$6.83M
$338 ﹤0.01%
33
-53
-62% -$548
DPCS
8923
DELISTED
DP Cap Acquisition Corp I Class A Ordinary Shares
DPCS
$337 ﹤0.01%
+30
New +$335
WESTW
8924
DELISTED
Westrock Coffee Company Warrants
WESTW
$333 ﹤0.01%
150
+87
+138% +$196
XUSP icon
8925
Innovator Uncapped Accelerated US Equity ETF
XUSP
$51M
$332 ﹤0.01%
+9
New +$314

Similar funds

UBS Group's Q2 2024 Portfolio in Review

As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

UBS Group's Q2 2024 filing shows 1,227 new, 3,693 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
  • UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
  • UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
  • UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
  • UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
  • UBS Group opened 1,227 new positions and closed 1,043 in Q2 2024.
  • UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.

Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.